[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Wafergen Bio-Sys Cmn (WGBS)

Wafergen Bio-Sys Cmn (WGBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Wafergen Bio-Sys Cmn 34700 CAMPUS DRIVE FREMONT CA 94555 USA

www.wafergen.com P: 510-651-4450

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

WaferGen Biosystems, Inc., a development stage company, engages in the development, manufacture, and sale of systems for gene expression, genotyping, and stem cell research for the life sciences, pharmaceutical industries, biomarker discovery and diagnostic products industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. This innovative system, combined with next-generation chemistry and optimized assays being developed by WaferGen, promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. It offers SmartSlide Micro-Incubation system that provides a controlled environment and physiological conditions for imaging studies, allowing researchers to characterize, differentiate, and proliferate various cells. WaferGen's revolutionary systems are the first of their kind, providing researchers with critical performance advantages that are not available with existing technologies.

Key Statistics

Overview:

Market Capitalization, $K 26,151
Shares Outstanding, K 3,790
% of Insider Shareholders 5.78%
% of Institutional Shareholders 10.80%

Financials:

Annual Sales, $ 7,170 K
Annual Net Income, $ -15,320 K
Last Quarter Sales, $ 2,390 K
Last Quarter Net Income, $ -3,670 K

Growth:

1-Year Return 102.86%
3-Year Return -94.48%
5-Year Return -99.27%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/14/17
Earnings Per Share ttm -4.60
EPS Growth vs. Prev Qtr 26.92%
EPS Growth vs. Prev Year 68.85%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 11/29/16

WGBS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -221.83%
Return-on-Assets % -95.23%
Profit Margin % -213.67%
Debt/Equity N/A
Price/Sales 2.83
Price/Cash Flow N/A
Price/Book 18.01
Book Value/Share 0.97
Interest Coverage 0.00
60-Month Beta 1.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.